References
- Nickerson M. Vasodilator drugs. The Pharmacological Basis of Therapeutics, 5th ed., L. S. Goodman, A. Gilman. Macmillan, New York 1975; 735
- Ritschel W. A., Hammer G. V. Pharmacokinetics of papaverine in man. Int. J. Clin. Pharmacol. 1977; 15: 227
- Elek S. R., Katz I. N. Some clinical uses of papaverine in heart disease. J. Am. Med. Assoc 1942; 120: 434
- Gray W., Riseman J. E. F., Stearns S. Papaverine in the treatment of coronary-artery disease. N. Engl. J. Med. 1945; 232: 389
- Rannov-Jessen U., Tjernlund A. Hepatotoxicity due to treatment with papaverine. N. Engl. J. Med. 1969; 281: 1333
- Kiaer H. W., Olsen S., Rannov-Jessen U. Hepatotoxicity of papaverine, histologic lesions. Arch. Pathol. 1974; 98: 292
- Marbach E. P., Weil M. H. Rapid enzymatic measurement of blood lactate and pyruvate. Clin. Chem. 1967; 13: 314
- Browning E. T., Groppi V. E., Jr., Kon C. Papaverine, a potent inhibitor of respiration in C-6 astrocytonia cells. Mol. Pharmacol. 1974; 10: 175
- Kowal J., Horano Y. Adrenal cells in tissue culture. The effect of papaverine and amytol on steroidogenesis, respiration, and replication. Arch. Biochem. Biophys. 1974; 163: 466
- Santi R., Contessa A. R., Ferrari M. Spasmolytic effect of papaverine and inhibition of the oxidative phosphorylation. Biochem. Biophys. Res. Commun. 1963; 11: 156
- Luciani S., Bortignon C., Santi R. Effetto della papaverina sulle reazione di trasferimento di enegia in mitochondri di fegato di ralto. Boll. Soc. Ital. Biol. Sper. 1967; 43: 410
- Luciani S., Contessa A. R., Bortignon C. Effectto della papaverina sulla ossidazione del succinato. Boll. Soc. Ital. Biol. Sper. 1967; 43: 409
- Tsuda S., Urakawa N., Saito Y. The inhibitory effect of papaverine on respiration-dependent contracture of guinea pig taenia coli in high-K medium. I. The relationship between contracture and respiration. Jpn. J. Pharmacol. 1977; 27: 833
- Isuda S., Urakawa N., Fukami J. The inhibitory effect of papaverine on respiration-dependent contracture of guinea pig taenia coli in high-K medium. II. Inhibition of mitochondrial respiration. Jpn. J. Pharmacol. 1977; 27: 845
- Tsuda S., Urakawa N., Fukami J. The inhibitory effect of papaverine on respiration-dependent contracture of guinea pig taenia coli in high-K medium. III. The differential effect of papaverine and rotenone on DT diapharase. Jpn. J. Pharmacol. 1977; 27: 855
- Relman R. S. Lactic acidosis. Acid-Base and Potassium Homeostasis, Brenner, Stein. Churchill Living-stone. 1978; Vol. 2: 65–100
- Hanna P. E., O'Dea R. F., Goldberg N. D. Phosphodiesterase inhibition by papaverine and structurally related grounds. Biochem. Pharmacol. 1972; 21: 226
- Miyamoto M., Takayanagi I., Ohkubo H., Takazi K. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases. Jpn. J. Pharmacol. 1976; 26: 114
- Demesy-Waeldele F., Stoclet J. C. Effect of papaverine on cyclic nucleotide levels in the isolated rat aorta. Eur. J. Pharmacol. 1977; 46: 63
- Andersson R. K., Nilsson K., Wikberg J., Johansson S., Mohne-Lundholm E., Lundholm L. Adv. Cyclic Nucleotide Res. 1975; 5: 491